Lantern Pharma Inc. (NASDAQ:LTRN – Get Free Report) saw a large decrease in short interest in September. As of September 15th, there was short interest totalling 179,100 shares, a decrease of 19.8% from the August 31st total of 223,300 shares. Currently, 2.2% of the shares of the stock are sold short. Based on an average […]